These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33541085)

  • 21. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C; Dessolin J; Grellier P; Davioud-Charvet E
    Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
    Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteases of malaria parasites: new targets for chemotherapy.
    Rosenthal PJ
    Emerg Infect Dis; 1998; 4(1):49-57. PubMed ID: 9452398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Dawood WA; Fisher GM; Kinnen FJM; Anzenhofer C; Skinner-Adams T; Alves Avelar L; Asfaha Y; Kurz T; Andrews KT
    Exp Parasitol; 2024 Mar; 258():108716. PubMed ID: 38340779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia.
    Gawel JM; Shouksmith AE; Raouf YS; Nawar N; Toutah K; Bukhari S; Manaswiyoungkul P; Olaoye OO; Israelian J; Radu TB; Cabral AD; Sina D; Sedighi A; de Araujo ED; Gunning PT
    Eur J Med Chem; 2020 Sep; 201():112411. PubMed ID: 32615502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1.
    Huang Z; Li R; Tang T; Ling D; Wang M; Xu D; Sun M; Zheng L; Zhu F; Min H; Boonhok R; Ding Y; Wen Y; Chen Y; Li X; Chen Y; Liu T; Han J; Miao J; Fang Q; Cao Y; Tang Y; Cui J; Xu W; Cui L; Zhu J; Wong G; Li J; Jiang L
    Cell Discov; 2020 Dec; 6(1):93. PubMed ID: 33311461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.
    Mackwitz MKW; Hesping E; Eribez K; Schöler A; Antonova-Koch Y; Held J; Winzeler EA; Andrews KT; Hansen FK
    Eur J Med Chem; 2021 Feb; 211():113065. PubMed ID: 33360801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
    Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
    ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
    Zhan W; Zhang H; Ginn J; Leung A; Liu YJ; Michino M; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Chelebieva S; Tumwebaze PK; Lafuente-Monasterio MJ; Martinez-Martinez MS; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Meinke PT; Nathan CF; Kirkman LA; Lin G
    Angew Chem Int Ed Engl; 2021 Apr; 60(17):9279-9283. PubMed ID: 33433953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults.
    Koehne E; Kreidenweiss A; Zoleko Manego R; McCall M; Mombo-Ngoma G; Mackwitz MKW; Hansen FK; Held J
    Sci Rep; 2019 Nov; 9(1):17336. PubMed ID: 31758015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.
    Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B
    Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico identification of inhibitors against Plasmodium falciparum histone deacetylase 1 (PfHDAC-1).
    Kumar A; Dhar SK; Subbarao N
    J Mol Model; 2018 Aug; 24(9):232. PubMed ID: 30109440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.
    Tavares MT; Krüger A; Yan SLR; Waitman KB; Gomes VM; de Oliveira DS; Paz F; Hilscher S; Schutkowski M; Sippl W; Ruiz C; Toledo MFZJ; Hassimotto NMA; Machado-Neto JA; Poso A; Cameron MD; Bannister TD; Palmisano G; Wrenger C; Kronenberger T; Parise-Filho R
    Sci Rep; 2023 Nov; 13(1):21006. PubMed ID: 38030668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
    Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
    Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The fight against drug-resistant malaria: novel plasmodial targets and antimalarial drugs.
    Choi SR; Mukherjee P; Avery MA
    Curr Med Chem; 2008; 15(2):161-71. PubMed ID: 18220771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.